BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3791355)

  • 1. Changes in creatine phosphate, inorganic phosphate, and the purine pattern in dog hearts with time of coronary artery occlusion and effect thereon of mioflazine, a nucleoside transport inhibitor.
    Van Belle H; Wynants J; Xhonneux R; Flameng W
    Cardiovasc Res; 1986 Sep; 20(9):658-64. PubMed ID: 3791355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral pretreatment with mioflazine completely changes the pattern and remarkably prolongs the accumulation of nucleosides in ischemic and reperfused myocardium.
    Van Belle H; Xhonneux R; Flameng W; Wynants J
    Basic Res Cardiol; 1986; 81(4):407-16. PubMed ID: 3778420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation and release of nucleosides in the ischemic myocardium. Is the guinea-pig the exception?
    Van Belle H; Wynants J; Goossens F
    Basic Res Cardiol; 1985; 80(6):653-60. PubMed ID: 4091781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and functional effects of nucleoside transport inhibition in the isolated cat heart.
    Van Belle H; Goossens F; Wynants J
    J Mol Cell Cardiol; 1989 Aug; 21(8):797-805. PubMed ID: 2778816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hypothermic ischemia on purine catabolism in canine, primate, and human myocardium.
    Möllhoff T; Sukehiro S; Hendrickx M; Van Belle H; Flameng W
    Thorac Cardiovasc Surg; 1991 Aug; 39(4):187-92. PubMed ID: 1948966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of mioflazine on canine coronary blood flow and on adenine nucleotide and nucleoside content under normal and ischemic conditions.
    Buchwald A; Ito BR; Schaper W
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):213-21. PubMed ID: 2441173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced postischemic ATP repletion by pharmacological inhibition of nucleoside washout and catabolism.
    Henrichs KJ; Matsuoka H; Schaper W
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):694-700. PubMed ID: 2457765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of myocardial high-energy phosphates during twenty-four hours of cold storage. Effects of cardioplegic versus noncardioplegic arrest.
    Masuda M; Sukehiro S; Möllhoff T; Lu HR; Van Belle H; Flameng W
    J Thorac Cardiovasc Surg; 1992 May; 103(5):993-1000. PubMed ID: 1569780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute changes in high energy phosphates, nucleotide derivatives, and contractile force in ischaemic and nonischaemic canine myocardium following coronary occlusion.
    Jones CE; Thomas JX; Parker JC; Parker RE
    Cardiovasc Res; 1976 May; 10(3):275-82. PubMed ID: 954015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional myocardial energetics during brief periods of coronary occlusion and reperfusion: Comparison with S-T segment changes.
    Vial C; Font B; Goldschmidt D; Pearlman AS; DeLaye J
    Cardiovasc Res; 1978 Aug; 12(8):470-6. PubMed ID: 719659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nucleoside transport inhibition on adenosine and hypoxanthine accumulation in the ischemic human myocardium.
    Masuda M; Sukehiro S; Möllhoff T; Van Belle H; Flameng W
    Arch Int Pharmacodyn Ther; 1993; 322():45-54. PubMed ID: 8215716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of repetitive coronary occlusions on myocardial adenine nucleosides, high energy phosphates and ultrastructure.
    Henrichs KJ; Matsuoka H; Schaper J
    Basic Res Cardiol; 1987; 82(6):557-65. PubMed ID: 3435401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nucleoside transport inhibition on long-term ex vivo preservation of canine hearts.
    Masuda M; Chang-Chun C; Möllhoff T; Van Belle H; Flameng W
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1610-7. PubMed ID: 1453725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic versus adult myocardium: adenine nucleotide degradation during ischemia.
    Mask WK; Abd-Elfattah AS; Jessen M; Brunsting LA; Lekven J; Wechsler AS
    Ann Thorac Surg; 1989 Jul; 48(1):109-12. PubMed ID: 2764588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine deaminase inhibition and myocardial purine release during normoxia and ischaemia.
    Achterberg PW; Harmsen E; de Jong JW
    Cardiovasc Res; 1985 Oct; 19(10):593-8. PubMed ID: 4053134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated with anatomic evidence of necrosis.
    DeBoer LW; Ingwall JS; Kloner RA; Braunwald E
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5471-5. PubMed ID: 6933566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of uridine supply on glycogen resynthesis after ischaemia in the isolated perfused rat heart.
    Aussedat J
    Cardiovasc Res; 1983 Mar; 17(3):145-51. PubMed ID: 6871904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between coronary artery stenosis and myocardial purine metabolism, histology and regional function in humans.
    Flameng W; Vanhaecke J; Van Belle H; Borgers M; De Beer L; Minten J
    J Am Coll Cardiol; 1987 Jun; 9(6):1235-42. PubMed ID: 3584715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIGH ENERGY PHOSPHATE COMPOUNDS IN THE MYOCARDIUM DURING EXPERIMENTAL CONGESTIVE HEART FAILURE. PURINE AND PYRIMIDINE NUCLEOTIDES, CREATINE, AND CREATINE PHOSPHATE IN NORMAL AND IN FAILING HEARTS.
    FOX AC; WIKLER NS; REED GE
    J Clin Invest; 1965 Feb; 44(2):202-18. PubMed ID: 14260162
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
    Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
    Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.